Successful treatment of South American rattlesnake (Crotalus durissus terrificus) envenomation with Crotalidae polyvalent immune Fab (CroFab™)

doi:10.1007/s13181-010-0100-z

Case Reports

. 2011 Mar;7(1):44-6.

doi: 10.1007/s13181-010-0100-z.

Successful treatment of South American rattlesnake (Crotalus durissus terrificus) envenomation with Crotalidae polyvalent immune Fab (CroFab™)

Michael J Lynch¹, Seth C Ritter, Robert D Cannon

Affiliations

Affiliation

¹ Division of Medical Toxicology, Department of Emergency Medicine, University of Pittsburgh Medical Center, DL-45, 200 Lothrop St., Pittsburgh, PA, 15213, USA. lyncmj@upmc.edu

PMID: 20658221
PMCID: PMC3614103
DOI: 10.1007/s13181-010-0100-z

Case Reports

Successful treatment of South American rattlesnake (Crotalus durissus terrificus) envenomation with Crotalidae polyvalent immune Fab (CroFab™)

Michael J Lynch et al. J Med Toxicol. 2011 Mar.

. 2011 Mar;7(1):44-6.

doi: 10.1007/s13181-010-0100-z.

Authors

Michael J Lynch¹, Seth C Ritter, Robert D Cannon

Affiliation

¹ Division of Medical Toxicology, Department of Emergency Medicine, University of Pittsburgh Medical Center, DL-45, 200 Lothrop St., Pittsburgh, PA, 15213, USA. lyncmj@upmc.edu

PMID: 20658221
PMCID: PMC3614103
DOI: 10.1007/s13181-010-0100-z

No abstract available

PubMed Disclaimer

Cited by

Biological and Medical Aspects Related to South American Rattlesnake Crotalus durissus (Linnaeus, 1758): A View from Colombia.
Cañas CA. Cañas CA. Toxins (Basel). 2022 Dec 15;14(12):875. doi: 10.3390/toxins14120875. Toxins (Basel). 2022. PMID: 36548772 Free PMC article. Review.
Immunotherapeutic potential of Crotoxin: anti-inflammatory and immunosuppressive properties.
Sartim MA, Menaldo DL, Sampaio SV. Sartim MA, et al. J Venom Anim Toxins Incl Trop Dis. 2018 Dec 17;24:39. doi: 10.1186/s40409-018-0178-3. eCollection 2018. J Venom Anim Toxins Incl Trop Dis. 2018. PMID: 30564276 Free PMC article. Review.
An empirical approach towards the efficient and optimal production of influenza-neutralizing ovine polyclonal antibodies demonstrates that the novel adjuvant CoVaccine HT™ is functionally superior to Freund's adjuvant.
Stevens NE, Fraser CK, Alsharifi M, Brown MP, Diener KR, Hayball JD. Stevens NE, et al. PLoS One. 2013 Jul 23;8(7):e68895. doi: 10.1371/journal.pone.0068895. Print 2013. PLoS One. 2013. PMID: 23894371 Free PMC article.
Preserved antiviral adaptive immunity following polyclonal antibody immunotherapy for severe murine influenza infection.
Stevens NE, Hatjopolous A, Fraser CK, Alsharifi M, Diener KR, Hayball JD. Stevens NE, et al. Sci Rep. 2016 Jul 6;6:29154. doi: 10.1038/srep29154. Sci Rep. 2016. PMID: 27380890 Free PMC article.

References

1. Sano-Martins IS, Tomy SC, Campolina D, Dias MB, de Castro SC, de Sousa-e-Silva MC, Amaral CF, et al. Coagulopathy following lethal and non-lethal envenoming of humans by the South American rattlesnake (Crotalus durissus) in Brazil. QJM. 2001;94(10):551–559. doi: 10.1093/qjmed/94.10.551. - DOI - PubMed
1. Dart RC, Seifert SA, Boyer LV, Clark RF, Hall E, McKinney P, McNally J, et al. A randomized multicenter trial of cpolyvalent immune Fab (ovine) antivenom for the treatment for crotaline snakebite in the United States. Arch Intern Med. 2001;161(16):2030–2036. doi: 10.1001/archinte.161.16.2030. - DOI - PubMed
1. Jurkovich GJ, Luterman A, McCullar K, Ramenofsky ML, Curreri PW. Complications of Crotalidae antivenin therapy. J Trauma. 1988;28(7):1032–1037. doi: 10.1097/00005373-198807000-00020. - DOI - PubMed
1. Ruha AM, Curry SC, Beuhler M, Katz K, Brooks DE, Graeme KA, Wallace K, et al. Initial postmarketing experience with Crotalidae polyvalent immune Fab for treatment of rattlesnake envenomation. Ann Emerg Med. 2002;39(6):609–615. doi: 10.1067/mem.2002.123698. - DOI - PubMed
1. Boyer LV, Seifert SA, Cain JS. Recurrence phenomena after immunoglobulin therapy for snake envenomations: Part 2. Guidelines for clinical management with crotaline Fab antivenom. Ann Emerg Med. 2001;37(2):196–201. doi: 10.1067/mem.2001.113134. - DOI - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources

[1] Sano-Martins IS, Tomy SC, Campolina D, Dias MB, de Castro SC, de Sousa-e-Silva MC, Amaral CF, et al. Coagulopathy following lethal and non-lethal envenoming of humans by the South American rattlesnake (Crotalus durissus) in Brazil. QJM. 2001;94(10):551–559. doi: 10.1093/qjmed/94.10.551. - DOI - PubMed

[2] Sano-Martins IS, Tomy SC, Campolina D, Dias MB, de Castro SC, de Sousa-e-Silva MC, Amaral CF, et al. Coagulopathy following lethal and non-lethal envenoming of humans by the South American rattlesnake (Crotalus durissus) in Brazil. QJM. 2001;94(10):551–559. doi: 10.1093/qjmed/94.10.551. - DOI - PubMed

[3] Dart RC, Seifert SA, Boyer LV, Clark RF, Hall E, McKinney P, McNally J, et al. A randomized multicenter trial of cpolyvalent immune Fab (ovine) antivenom for the treatment for crotaline snakebite in the United States. Arch Intern Med. 2001;161(16):2030–2036. doi: 10.1001/archinte.161.16.2030. - DOI - PubMed

[4] Dart RC, Seifert SA, Boyer LV, Clark RF, Hall E, McKinney P, McNally J, et al. A randomized multicenter trial of cpolyvalent immune Fab (ovine) antivenom for the treatment for crotaline snakebite in the United States. Arch Intern Med. 2001;161(16):2030–2036. doi: 10.1001/archinte.161.16.2030. - DOI - PubMed

[5] Jurkovich GJ, Luterman A, McCullar K, Ramenofsky ML, Curreri PW. Complications of Crotalidae antivenin therapy. J Trauma. 1988;28(7):1032–1037. doi: 10.1097/00005373-198807000-00020. - DOI - PubMed

[6] Jurkovich GJ, Luterman A, McCullar K, Ramenofsky ML, Curreri PW. Complications of Crotalidae antivenin therapy. J Trauma. 1988;28(7):1032–1037. doi: 10.1097/00005373-198807000-00020. - DOI - PubMed

[7] Ruha AM, Curry SC, Beuhler M, Katz K, Brooks DE, Graeme KA, Wallace K, et al. Initial postmarketing experience with Crotalidae polyvalent immune Fab for treatment of rattlesnake envenomation. Ann Emerg Med. 2002;39(6):609–615. doi: 10.1067/mem.2002.123698. - DOI - PubMed

[8] Ruha AM, Curry SC, Beuhler M, Katz K, Brooks DE, Graeme KA, Wallace K, et al. Initial postmarketing experience with Crotalidae polyvalent immune Fab for treatment of rattlesnake envenomation. Ann Emerg Med. 2002;39(6):609–615. doi: 10.1067/mem.2002.123698. - DOI - PubMed

[9] Boyer LV, Seifert SA, Cain JS. Recurrence phenomena after immunoglobulin therapy for snake envenomations: Part 2. Guidelines for clinical management with crotaline Fab antivenom. Ann Emerg Med. 2001;37(2):196–201. doi: 10.1067/mem.2001.113134. - DOI - PubMed

[10] Boyer LV, Seifert SA, Cain JS. Recurrence phenomena after immunoglobulin therapy for snake envenomations: Part 2. Guidelines for clinical management with crotaline Fab antivenom. Ann Emerg Med. 2001;37(2):196–201. doi: 10.1067/mem.2001.113134. - DOI - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Successful treatment of South American rattlesnake (Crotalus durissus terrificus) envenomation with Crotalidae polyvalent immune Fab (CroFab™)

Affiliation

Successful treatment of South American rattlesnake (Crotalus durissus terrificus) envenomation with Crotalidae polyvalent immune Fab (CroFab™)

Authors

Affiliation

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources